Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

December 01, 2011

CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 08, 2011

    Novartis, Celgene Hit Teva Again Over ADHD Drug Patents

    Celgene Corp. and Novartis AG recently hit Teva Pharmaceuticals USA Inc. with a fresh patent infringement suit in New Jersey over Teva's plan to market a generic version of attention deficit hyperactivity disorder drug Focalin XR, the latest in a long-running battle between the companies.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login